The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial (vol 30, pg 207, 2024)
Lindsay B. Kilburn,Dong-Anh Khuong-Quang,Jordan R. Hansford,Daniel Landi,Jasper van der Lugt,Sarah E. S. Leary,Pablo Hernaiz Driever,Simon Bailey,Sebastien Perreault,Geoffrey McCowage,Angela J. Waanders,David S. Ziegler,Olaf Witt,Patricia A. Baxter,Hyoung Jin Kang,Timothy E. Hassall,Jung Woo Han, Darren Hargrave,Andrea T. Franson,Michal Yalon Oren,Helen Toledano,Valerie Larouche,Cassie Kline,Mohamed S. Abdelbaki,Nada Jabado,Nicholas G. Gottardo,Nicolas U. Gerber,Nicholas S. Whipple,Devorah Segal,Susan N. Chi, Liat Oren,Enrica E. K. Tan,Sabine Mueller,Izzy Cornelio, Lisa Mcleod,Xin Zhao,Ashley Walter,Daniel Da Costa,Peter Manley,Samuel C. Blackman,Roger J. Packer,Karsten Nysom NATURE MEDICINE(2024)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)